Konstantinos Chiotis, MD, PhD
Konstantinos Chiotis, MD, PhD
Postdoctoral fellow @ Karolinska Institutet
Verified email at ki.se
Title
Cited by
Cited by
Year
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ...
The Lancet Neurology 16 (8), 661-676, 2017
2142017
Tau PET imaging: present and future directions
L Saint-Aubert, L Lemoine, K Chiotis, A Leuzy, E Rodriguez-Vieitez, ...
Molecular neurodegeneration 12 (1), 19, 2017
1492017
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease
E Rodriguez-Vieitez, L Saint-Aubert, SF Carter, O Almkvist, K Farid, ...
Brain 139 (3), 922-936, 2016
1382016
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
K Chiotis, L Saint-Aubert, I Savitcheva, V Jelic, P Andersen, M Jonasson, ...
European journal of nuclear medicine and molecular imaging 43 (9), 1686-1699, 2016
942016
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
A Leuzy, K Chiotis, SG Hasselbalch, JO Rinne, A de Mendonça, M Otto, ...
Brain 139 (9), 2540-2553, 2016
712016
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia
K Chiotis, L Saint-Aubert, E Rodriguez-Vieitez, A Leuzy, O Almkvist, ...
Molecular psychiatry 23 (7), 1666-1673, 2018
572018
Tau PET imaging in neurodegenerative tauopathies—still a challenge
A Leuzy, K Chiotis, L Lemoine, PG Gillberg, O Almkvist, ...
Molecular psychiatry 24 (8), 1112-1134, 2019
482019
Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology
M Jonasson, A Wall, K Chiotis, L Saint-Aubert, H Wilking, M Sprycha, ...
Journal of Nuclear Medicine 57 (4), 574-581, 2016
422016
Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer’s disease
L Saint-Aubert, O Almkvist, K Chiotis, R Almeida, A Wall, A Nordberg
Alzheimer's research & therapy 8 (1), 38, 2016
382016
Concordance and diagnostic accuracy of [11C] PIB PET and cerebrospinal fluid biomarkers in a sample of patients with mild cognitive impairment and Alzheimer's disease
A Leuzy, SF Carter, K Chiotis, O Almkvist, A Wall, A Nordberg
Journal of Alzheimer's Disease 45 (4), 1077-1088, 2015
352015
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
K Chiotis, L Saint-Aubert, M Boccardi, A Gietl, A Picco, A Varrone, ...
Neurobiology of aging 52, 214-227, 2017
32*2017
A cross-validation of FDG-and amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer’s disease in a clinical setting
L Iaccarino, K Chiotis, P Alongi, O Almkvist, A Wall, C Cerami, V Bettinardi, ...
Journal of Alzheimer's Disease 59 (2), 603-614, 2017
312017
Comparison of early-phase 11C-deuterium-l-deprenyl and 11C-Pittsburgh compound B PET for assessing brain perfusion in Alzheimer disease
E Rodriguez-Vieitez, SF Carter, K Chiotis, L Saint-Aubert, A Leuzy, ...
Journal of Nuclear Medicine 57 (7), 1071-1077, 2016
302016
Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding
L Lemoine, A Leuzy, K Chiotis, E Rodriguez-Vieitez, A Nordberg
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 10, 232-236, 2018
292018
Role of anthropometric characteristics in idiopathic carpal tunnel syndrome
K Chiotis, N Dimisianos, A Rigopoulou, A Chrysanthopoulou, E Chroni
Archives of physical medicine and rehabilitation 94 (4), 737-744, 2013
292013
Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer’s disease
E Rodriguez-Vieitez, A Leuzy, K Chiotis, L Saint-Aubert, A Wall, ...
Journal of Cerebral Blood Flow & Metabolism 37 (2), 740-749, 2017
282017
Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain
K Chiotis, P Stenkrona, O Almkvist, V Stepanov, D Ferreira, R Arakawa, ...
European journal of nuclear medicine and molecular imaging 45 (9), 1605-1617, 2018
14*2018
Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis
A Leuzy, I Savitcheva, K Chiotis, J Lilja, P Andersen, N Bogdanovic, ...
European journal of nuclear medicine and molecular imaging 46 (6), 1276-1286, 2019
8*2019
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
A Leuzy, C Cicognola, K Chiotis, L Saint-Aubert, L Lemoine, N Andreasen, ...
European journal of nuclear medicine and molecular imaging 46 (5), 1152-1163, 2019
82019
Spatial normalization of 18F-flutemetamol PET images using an adaptive principal-component template
J Lilja, A Leuzy, K Chiotis, I Savitcheva, J Sörensen, A Nordberg
Journal of Nuclear Medicine 60 (2), 285-291, 2019
8*2019
The system can't perform the operation now. Try again later.
Articles 1–20